Health Care · Biotechnology
Market cap divided by sales over the last 12 months. Useful for companies that aren’t profitable yet.
Latest P/S Ratio
1.97x
As of Sep 29, 2026
Beyond P/S Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/S Ratio |
|---|---|
| Sep 29, 2026 | 1.97x |
| Sep 28, 2026 | 2.02x |
| Sep 25, 2026 | 2.03x |
| Sep 24, 2026 | 2.07x |
| Sep 23, 2026 | 2.10x |
| Sep 22, 2026 | 1.97x |
| Sep 21, 2026 | 1.79x |
| Sep 18, 2026 | 1.68x |
P/S Ratio = Market Capitalization / Revenue (TTM)
P/S ignores profitability and capital structure, making it a simple but blunt valuation tool.
Read the general P/S Ratio definition, formula, and analyst usage guide.
P/S Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison